Blueprint Medicines Corp. (BPMC)

Sector:Health Care
Super Investor Stats:
Ownership count:1
Ownership rank:706
% of all portfolios:0.004%
History Portfolio Manager Activity Share change % change to portfolio
Q1  2024
Torray Funds Add 0.96% 185 0.00
Q4  2023
Torray Funds Reduce 22.41% 5,556 0.08
Q3  2023
Torray Funds Add 4.43% 1,051 0.01
Q2  2023
Torray Funds Add 0.58% 137 0.00
Q1  2023
Torray Funds Add 0.71% 167 0.00
Q4  2022
Torray Funds Add 34.02% 5,949 0.05
Q3  2022
Torray Funds Add 15.32% 2,323 0.03
Q2  2022
Torray Funds Add 21.42% 2,675 0.03
Q1  2022
Torray Funds Add 7.94% 919 0.01
Q4  2021
Torray Funds Reduce 27.41% 4,368 0.07
Q3  2021
Torray Funds Add 34.51% 4,089 0.06
Q2  2021
Torray Funds Add 2.98% 343 0.00
Stephen Mandel - Lone Pine Capital Sell 100.00% 2,709,138 0.96
Viking Global Investors Sell 100.00% 213,050 0.06
Q1  2021
Torray Funds Buy 11,506 0.18
Viking Global Investors Reduce 21.87% 59,631 0.02
Q4  2020
Stephen Mandel - Lone Pine Capital Buy 2,709,138 1.10
Viking Global Investors Reduce 80.94% 1,158,086 0.34
Q3  2020
Viking Global Investors Reduce 12.21% 198,949 0.07
Q2  2020
Viking Global Investors Add 1.83% 29,249 0.01
Q1  2020
Viking Global Investors Add 22.50% 293,926 0.09
Q4  2019
Viking Global Investors Add 62.98% 504,902 0.19
Q3  2019
Viking Global Investors Add 45.48% 250,599 0.10
Q2  2019
Viking Global Investors Reduce 16.34% 107,621 0.04
Q1  2018
Leon Cooperman Sell 100.00% 75,000 0.21
Q4  2017
Leon Cooperman Buy 75,000 0.21

* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.